Dimensional Fund Advisors LP Next Cure, Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Next Cure, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 85,853 shares of NXTC stock, worth $83,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares

85,853

Previous 86,559 0.82%

Holding current value

$83,277

Previous $137,000 14.6%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$1.33 - $1.78 $938 - $1,256	-706 Reduced 0.82%	85,853 $117,000
Q2 2024 Aug 09, 2024	BUY	$1.17 - $2.49 $826 - $1,757	706 Added 0.82%	86,559 $137,000
Q4 2023 Feb 07, 2024	SELL	$1.03 - $1.45 $10,163 - $14,307	-9,867 Reduced 10.31%	85,853 $97,000
Q3 2023 Nov 09, 2023	SELL	$1.29 - $1.84 $102,186 - $145,753	-79,214 Reduced 45.28%	95,720 $123,000
Q2 2023 Aug 09, 2023	SELL	$1.47 - $1.86 $44,517 - $56,328	-30,284 Reduced 14.76%	174,934 $314,000
Q1 2023 May 12, 2023	SELL	$1.46 - $1.83 $180,914 - $226,762	-123,914 Reduced 37.65%	205,218 $303,000
Q4 2022 Feb 09, 2023	SELL	$1.2 - $3.07 $181,830 - $465,181	-151,525 Reduced 31.52%	329,132 $464,000
Q3 2022 Nov 10, 2022	BUY	$2.72 - $5.19 $143,953 - $274,675	52,924 Added 12.37%	480,657 $1.32 Million
Q2 2022 Aug 12, 2022	BUY	$3.38 - $5.27 $251,742 - $392,509	74,480 Added 21.08%	427,733 $2.01 Million
Q1 2022 May 13, 2022	BUY	$4.76 - $6.24 $705,465 - $924,811	148,207 Added 72.28%	353,253 $1.72 Million
Q4 2021 Feb 09, 2022	BUY	$5.7 - $9.1 $786,126 - $1.26 Million	137,917 Added 205.45%	205,046 $1.23 Million
Q3 2021 Nov 12, 2021	SELL	$6.74 - $8.02 $341,589 - $406,461	-50,681 Reduced 43.02%	67,129 $452,000
Q2 2021 Aug 12, 2021	BUY	$7.6 - $10.28 $43,076 - $58,267	5,668 Added 5.05%	117,810 $946,000
Q1 2021 May 14, 2021	BUY	$9.81 - $13.88 $1.1 Million - $1.56 Million	112,142 New	112,142 $1.13 Million

Others Institutions Holding NXTC

# of Institutions

Shares Held

15.9M

Call Options Held

Put Options Held

View Full List

About NextCure, Inc.

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $26.9M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

More about NXTC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Next Cure, Inc. Transaction History